Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.

Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isol...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Safia S Aljedani, Tyler J Liban, Karen Tran, Ganesh Phad, Suruchi Singh, Viktoriya Dubrovskaya, Pradeepa Pushparaj, Paola Martinez-Murillo, Justas Rodarte, Alex Mileant, Vidya Mangala Prasad, Rachel Kinzelman, Sijy O'Dell, John R Mascola, Kelly K Lee, Gunilla B Karlsson Hedestam, Richard T Wyatt, Marie Pancera
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/5d1e169cb38444308637152c824457f6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:5d1e169cb38444308637152c824457f6
record_format dspace
spelling oai:doaj.org-article:5d1e169cb38444308637152c824457f62021-12-02T20:00:06ZStructurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.1553-73661553-737410.1371/journal.ppat.1009543https://doaj.org/article/5d1e169cb38444308637152c824457f62021-09-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.1009543https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isolated from non-human primates (NHPs) immunized with variants of a native flexibly linked (NFL) HIV-1 Env stabilized trimer derived from the tier 2 clade C 16055 strain. The antibodies displayed neutralizing activity against the autologous virus with potencies ranging from 0.005 to 3.68 μg/ml (IC50). Structural characterization using negative-stain EM and X-ray crystallography identified the variable region 2 (V2) of the 16055 NFL trimer to be the common epitope for these antibodies. The crystal structures revealed that the V2 segment adopts a β-hairpin motif identical to that observed in the 16055 NFL crystal structure. These results depict how vaccine-induced antibodies derived from different clonal lineages penetrate through the glycan shield to recognize a hypervariable region within V2 (residues 184-186) that is unique to the 16055 strain. They also provide potential explanations for the potent autologous neutralization of these antibodies, confirming the immunodominance of this site and revealing that multiple angles of approach are permissible for affinity/avidity that results in potent neutralizing capacity. The structural analysis reveals that the most negatively charged paratope correlated with the potency of the mAbs. The atomic level information is of interest to both define the means of autologous neutralization elicited by different tier 2-based immunogens and facilitate trimer redesign to better target more conserved regions of V2 to potentially elicit cross-neutralizing HIV-1 antibodies.Safia S AljedaniTyler J LibanKaren TranGanesh PhadSuruchi SinghViktoriya DubrovskayaPradeepa PushparajPaola Martinez-MurilloJustas RodarteAlex MileantVidya Mangala PrasadRachel KinzelmanSijy O'DellJohn R MascolaKelly K LeeGunilla B Karlsson HedestamRichard T WyattMarie PanceraPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 17, Iss 9, p e1009543 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Safia S Aljedani
Tyler J Liban
Karen Tran
Ganesh Phad
Suruchi Singh
Viktoriya Dubrovskaya
Pradeepa Pushparaj
Paola Martinez-Murillo
Justas Rodarte
Alex Mileant
Vidya Mangala Prasad
Rachel Kinzelman
Sijy O'Dell
John R Mascola
Kelly K Lee
Gunilla B Karlsson Hedestam
Richard T Wyatt
Marie Pancera
Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
description Understanding the molecular mechanisms by which antibodies target and neutralize the HIV-1 envelope glycoprotein (Env) is critical in guiding immunogen design and vaccine development aimed at eliciting cross-reactive neutralizing antibodies (NAbs). Here, we analyzed monoclonal antibodies (mAbs) isolated from non-human primates (NHPs) immunized with variants of a native flexibly linked (NFL) HIV-1 Env stabilized trimer derived from the tier 2 clade C 16055 strain. The antibodies displayed neutralizing activity against the autologous virus with potencies ranging from 0.005 to 3.68 μg/ml (IC50). Structural characterization using negative-stain EM and X-ray crystallography identified the variable region 2 (V2) of the 16055 NFL trimer to be the common epitope for these antibodies. The crystal structures revealed that the V2 segment adopts a β-hairpin motif identical to that observed in the 16055 NFL crystal structure. These results depict how vaccine-induced antibodies derived from different clonal lineages penetrate through the glycan shield to recognize a hypervariable region within V2 (residues 184-186) that is unique to the 16055 strain. They also provide potential explanations for the potent autologous neutralization of these antibodies, confirming the immunodominance of this site and revealing that multiple angles of approach are permissible for affinity/avidity that results in potent neutralizing capacity. The structural analysis reveals that the most negatively charged paratope correlated with the potency of the mAbs. The atomic level information is of interest to both define the means of autologous neutralization elicited by different tier 2-based immunogens and facilitate trimer redesign to better target more conserved regions of V2 to potentially elicit cross-neutralizing HIV-1 antibodies.
format article
author Safia S Aljedani
Tyler J Liban
Karen Tran
Ganesh Phad
Suruchi Singh
Viktoriya Dubrovskaya
Pradeepa Pushparaj
Paola Martinez-Murillo
Justas Rodarte
Alex Mileant
Vidya Mangala Prasad
Rachel Kinzelman
Sijy O'Dell
John R Mascola
Kelly K Lee
Gunilla B Karlsson Hedestam
Richard T Wyatt
Marie Pancera
author_facet Safia S Aljedani
Tyler J Liban
Karen Tran
Ganesh Phad
Suruchi Singh
Viktoriya Dubrovskaya
Pradeepa Pushparaj
Paola Martinez-Murillo
Justas Rodarte
Alex Mileant
Vidya Mangala Prasad
Rachel Kinzelman
Sijy O'Dell
John R Mascola
Kelly K Lee
Gunilla B Karlsson Hedestam
Richard T Wyatt
Marie Pancera
author_sort Safia S Aljedani
title Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
title_short Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
title_full Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
title_fullStr Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
title_full_unstemmed Structurally related but genetically unrelated antibody lineages converge on an immunodominant HIV-1 Env neutralizing determinant following trimer immunization.
title_sort structurally related but genetically unrelated antibody lineages converge on an immunodominant hiv-1 env neutralizing determinant following trimer immunization.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/5d1e169cb38444308637152c824457f6
work_keys_str_mv AT safiasaljedani structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT tylerjliban structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT karentran structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT ganeshphad structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT suruchisingh structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT viktoriyadubrovskaya structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT pradeepapushparaj structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT paolamartinezmurillo structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT justasrodarte structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT alexmileant structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT vidyamangalaprasad structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT rachelkinzelman structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT sijyodell structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT johnrmascola structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT kellyklee structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT gunillabkarlssonhedestam structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT richardtwyatt structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
AT mariepancera structurallyrelatedbutgeneticallyunrelatedantibodylineagesconvergeonanimmunodominanthiv1envneutralizingdeterminantfollowingtrimerimmunization
_version_ 1718375723436081152